Top of Page
Skip main navigation
Ph.D. Faculty

Ph.D. Faculty

Michelle A. Clark, Ph.D., Dean and Professor, Silverman College of Pharmacy
Michelle A. Clark, Ph.D.
Scholarly Activities:
  • Garnered in excess of $800,000 in research grants from the National Institutes of Health and private entities, as principal investigator and/or collaborator
  • Published more than 30 scientific papers, abstracts, and books
  • Served as a reviewer for numerous journals
  • Served as an American Heart Association local and national grant reviewer
  • Served as a reviewer for the NSU President’s Faculty Research and Development Grant
Research Focus:
  • Central and peripheral signaling pathways for blood pressure regulation and control
  • Role of the central renin angiotensin system in the regulation of cardiovascular and other diseases
Ana M. Castejon, Ph.D., Associate Dean, Graduate Programs and Associate Professor
Ana Castejon
Scholarly Activities:
  • Over 115 abstracts, reviews, and scientific research papers
  • Collaborated in NIH and Center of Medicare and Medicaid Services funded grants
  • Reviewer for several scientific journals, book publishers and federally funding agencies
Research Focus:
  • Cytoprotective effects of oxytocin
  • Oxidative stress and autism
  • Pharmacist intervention in minority populations of diabetics
  • Statins effects in vascular smooth muscle cells
Peter M. Gannett, Ph.D., Associate Dean and Professor, Research
Peter Gannett
Scholarly Activities:
  • Won $15 million in research grants from the National Institutes of Health, National Science Foundation, Department of Justice, and Department of Defense as co-investigator, principal investigator, or program director
  • Published over 300 scientific abstracts, papers, book chapters, and patents
  • Serves as a reviewer for 30 journals and numerous NIH, AHA, Israel, and DOD review panels and study sections
  • Associate editor for Molecules
Research Focus:
  • Synthesis and structure/conformation of carcinogenic adducted DNA and carcinogenesis
  • Cytochrome P450 enzymes: structure, drug design, and electron transfer processes
  • Nanobioscience: fabrication of point-of-care devices, nano-platforms for biochemistry
  • Computational biology
Benedict C. Albensi, Ph.D., BCMAS, CRQM, Chair and Professor, Co-Director of the B.R.A.I.N. Ctr.
Benedict Albensi
Scholarly Activities:
  • Over 300 abstracts, reviews,  book chapters, experimental studies, and oral presentations
  • Over $11 million dollars in grant support as PI, co-PI, co-Investigator, or collaborator
  • Served on over 30 grant review panels worldwide including NIH, DOD, etc.
  • Editor-in-Chief, Molecular Neurobiology; Associate Editor for Brain Injury and Journal of Alzheimer's Disease
  • Serves as Chair for ISTAART, Nutrition, Metabolism, and Dementia PIA, Alzheimer's Association, USA
  • Former Manitoba Dementia Research Chair and Everett Fund Chair for Alzheimer's Disease
  • Serves as Chair for Site Accreditation and Standards Institute (SASI) and former member of Alliance for Clinical Research Excellence and Safety (ACRES)
  • Former Board Director for the Alzheimer's Society (Manitoba), MitoCanada, and Brain Injury Association (Manitoba)
  • Recipient of the AAAS Willam D. Carey Annual Science Award for PhD thesis proposal - Science magazine
  • Listed in Expertscape.com as being in the top 1% worldwide in 6 areas (2011-2021) for the number of publications: Alzheimer Disease (0.33%), neurocognitive disorders (0.44%), dementia (0.57%), NF-kappa B (0.063%), memory (0.61%) & energy metabolism (0.28%)
Research Focus
  • Mechanisms of synaptic plasticity and memory impairment
  • Alzheimer's disease, brain injury, and epilepsy
  • NF-kB's activity in brain function and inflammation
  • Mitochondrial function
  • Animal models and clinical trials
Rais A. Ansari, Ph.D., Associate Professor
Rais Ansari
Scholarly Activities:
  • Published 20 scientific papers and abstracts
  • Reviewer of several journals
  • Grant submissions to NIH and several foundations
Research Focus:
  • Mechanism of alcohol-mediated hypertension
  • Toxicology
Jaleh Barar, Pharm.D., Ph.D.
Jaleh Barar
Scholarly Activities:
  • Published over 230 research and review articles in scientific journals
  • Co-authored 17 book chapters · Serves as the Editor-in-Chief of the “BioImpacts” journal
  • Acts as Peer-reviewer of several journals
  • Listed as one of the top 1% worldwide scientists by WoS-ESI ranking · H-index of 49 and i10-index of 141, according to Google Scholar.
Research Focus:
  • Cellular drug delivery/targeting
  • Multi-functional nanomedicines
  • Cancer drug development
  • Gene and protein Therapeutics
Luigi Cubeddu, M.D., Ph.D., Professor
Luigi Cubeddu, M.D., Ph.D.
Scholarly Activities:
  • 160 publications in peer-reviewed journals
  • 23 book chapters
  • 300 presentations at scientific meetings
Research Focus:
  • Mechanisms and treatment of hypertension associated with obesity
  • Salt-sensitive hypertension: epidemiology, genetic and acquired factors
  • Early detection of insulin resistance and abnormalities in glucose metabolism
  • Statin withdrawal syndrome
  • Antiviral actions of statins
Richard C. Deth, Ph.D., Professor
Richard Deth
Scholarly Activities:
  • Over 150 scientific publications, research abstracts, and book chapters
  • Published a monograph
  • Obtained more than $1 million in research funding from NIH, the American Heart Association, and private foundations
  • Reviewer for numerous grant applications and manuscripts
  • Expert witness in court cases concerning vaccination and autism
  • Holder of 4 patents pertaining to the diagnosis and treatment of schizophrenia and related disorders
Narasimman Gurusamy, M.Pharm, Ph.D.
Dr. Gurusamy
Scholarly Activities:
  • Received $231,000 in a research grant from the American Heart Association as principal investigator, and obtained research grants from King Khalid University as PI and co-PI
  • Published over 60 research articles, 55 scientific abstracts, and 6 book chapters
  • Serves as Grant Reviewer for American Heart Association. In the past, served as Grant Reviewer for Harvard Catalyst Pilot Research Grants and National Health and Medical Research Council – Australia
  • Serves as a reviewer for more than 35 journals and Editorial Borad member for 5 journals
  • Associate Editor for Frontiers in Cardiovascular Medicine
  • Guest Editor, Special Issue in Cells
  • Serves as PhD thesis reviewer for 6 universities in India
  • A recipient of Young Research Scientist Award from Antiviral Research Society, India, and Travel Awards from American Heart Association and University of Tennessee Health Science Center
Research Interest:
  • Elucidating the disease progression and repair mechanisms of cardiovascular diseases
  • Epigenetic regulation by non-coding RNAv
  • Treatment with exosomes, stem cells and pharmaceutical agents
  • Autophagy in cardiac diseases and repair
  • Epigenetic regulation by environmental factors and human lifestyle in inducing diseases
Young M. Kwon, Ph.D., Associate Professor
Young M. Kwon
Scholarly Activities:
  • Published 25 peer-reviewed scientific research papers
  • Authored two book chapters
  • Made 30 national and international scientific presentations
  • Co-authored 1 U.S. and several international patents
  • Reviewer for more than 10 scientific journals
Research Focus:
  • Targeted delivery and triggered release system for therapeutic macromolecules
  • Bioconjugate chemistry and PEGylation
  • Nonviral gene carriers and intracellular drug delivery
  • Protein stability and release from biodegradable polymer
Jean J. Latimer, Ph.D., Associate Professor; Director, AutoNation Institute for Breast Cancer Research & Care
Jean J. Latimer
Scholarly Activities:
  • Garnered over $17,455,000 in research grants from the National Institutes of Health, the American Cancer Society, the Department of Defense, and private entities
  • Published 35 scientific papers, reports, book chapters, and books
  • Presented over 100 scientific abstracts at national and international meetings
  • Served as a reviewer for five journals, the National Cancer Institute, NASA, and the American Cancer Society
  • Served as study section chairperson for the Komen for the Cure, the U.S. Department of Defense, and the New York State Department of Health
  • Authored 4 patents
Research Focus:
  • Loss of DNA repair as causative factor in cancer formation
  • Breast tissue engineering
  • Ancestral disparity in breast cancer development and pharmacogenomics
  • Drug resistance (via cancer stem cells) in childhood leukemia

AutoNation Institute for Breast Cancer Research & Care

Anastasios Lymperopoulos, Ph.D., Associate Professor
A. Lymperopoulos, Ph.D.
Scholarly Activities:
  • Fellow of the American Heart Association (FAHA) with its Basic Cardiovascular Sciences (BCVS) Council since 2011
  • American Heart Association (AHA)`s Post-Doctoral Research Fellow (2005-2008) and Scientist Development Grant (SDG) active awardee (AHA National Center) for $314,000
  • 2006 American Heart Association`s Melvin L. Marcus Young Investigator Award in Cardiovascular Sciences finalist and 2010 Cardiovascular Research Award of the Council on Basic Cardiovascular Sciences of the European Society of Cardiology (ESC) finalist
  • Over 28 publications in biomedical research journals
  • Chapter author in 3 educational textbooks
  • Peer reviewer for the American Heart Association`s Basic Cardiovascular Sciences Council
  • Member of the editorial boards of the American Journal of Cardiovascular Disease and the Journal of Carcinogenesis and Mutagenesis
  • Scientific manuscript reviewer for five journals
  • Co-inventor in two provisional patents
Research Focus:
  • Cardiovascular biology/pharmacology and gene therapy, with a focus on adrenergic system regulation in heart failure
  • Novel roles of G-protein coupled receptor kinases and their co-factors
Dmitriy Minond, Ph.D., Associate Professor
Dmitriy Minond, Ph.D.
Scholarly Activities
  • Obtained more than $3,500,000.00 in research grants from NIH, State of Florida, private organizations, and intramural mechanisms as a principal investigator and co-investigator
  • Inventor and co-inventor on several patents
  • Published more than 50 scientific papers and book chapters
  • Presented in multiple international and national research conferences
  • Served as a reviewer for numerous journals
  • Served as a reviewer for NIH, NSU President’s Faculty Research and Development Grant, and Department of Defense
Research Focus:
  • Cancer drug and target discovery
  • Metalloproteinase enzymology, drug and probe discovery
Enrique A. Nieves, Ph.D., Clinical Assistant Professor
Enrique Nieves
Scholarly Activities:
  • Served as reviewer for two scientific journals
  • Organized a symposium on nanotechnology applications in drug delivery in San Juan, P.R.
  • Established research collaboration with local and international universities
  • One-time recipient of the Health Professions Division Research Grant
  • Various poster and podium presentations at professional meetings
  • Author or co-author of U.S. and international patents
Research Focus:
  • Applications of nanotechnology in drug product development and pharmaceutical process designs in small and large scale
  • Applications of PAT technologies in drug development and manufacturing
  • Development of co-excipients for improved drug formulations
  • Nanotechnology applications in the extraction and isolation of new drugs from natural sources
  • Applied research in new technology applications in drug design and development from molecule to market

Yadollah Omidi, Pharm.D., Ph.D., Professor
Dr. Yadollah Omidi
Scholarly Activities:
  • Published over 320 scientific papers, and book chapters
  • Acts as the Editor-in-Chief of Bioimpacts and Editorial Board of Nanomedicine, Biologicals, BMC Pharmacology and Toxicology, DARU Journal of Pharmaceutical Sciences
  • Serves as a reviewer for 35 journals
  • Contributed to several grants
  • Listed as the top 1% of scientists worldwide by ESI-WoS
Research Focus:
  • Multifunctional nanomedicines and theranostics
  • Targeted drug delivery systems for detrimental diseases
  • Bioengineering: tissue engineering and diagnostic nanobiosystems
  • Computational biology
  • Biologicals: vaccines and immunotherapies

More on Google Scholar.

Hamid Omidian, Ph.D., Professor
Hamid Omidian
Scholarly Activities:
  • Primary inventor of 3 issued U.S. patents, 11 patent applications, and 31 invention disclosures
  • Author or co-author of 120 peer-reviewed journal publications and 188 conference presentations
  • Author or co-author of 37 books and book chapters
  • Principal investigator, co-principal investigator, and co-investigator of grant proposals and industry contracts worth $2.9 million
  • Three-time Golden Apple nominee and one-time Golden Apple winner for teaching excellence
  • Google Scholar’s citations of 7644, h-index of 34, and i10-index of 65
  • On the editorial board of several journals
Research Focus:
  • Opioid Abuse and Overdose
  • Abuse-Deterrent Formulations
  • Gastric Retention and Oral Retentive Drug Delivery
  • Pharmaceutical Polymers and Hydrogels
  • Drug Delivery Technologies
  • Pharmaceutical Formulations
Appu Rathinavelu, Ph.D., Professor, Executive Director Rumbaugh Goodwin Institute
Appu Rathinavelu
Scholarly Activities:
  • Garnered approximately $200,000 in research funding
  • Published over 50 articles in refereed journals
  • Made 100 presentations at regional and national scientific meetings
  • Primary inventor of 6 patents and co-author of 1 patent application
  • Co-authored 3 book chapters and 1 book
  • Reviewer for more than 10 scientific journals
Research Focus:
  • Drug discovery and testing
  • Biomarker development for disease diagnosis and management
  • Gene expression analysis in highly metastatic tumors
  • Understanding intracellular pathway regulating angiogenesis
  • ANP receptor regulation and cardiovascular function
Robert C. Speth, Ph.D., Professor
Robert Speth
Scholarly Activities:
  • Published over 190 manuscripts in peer-reviewed journals
  • Authored 39 book chapters and other scholarly publications
  • Co-edited 1 book
  • Co-edited special issue of the International Journal of Hypertension
  • Organized symposia for the Society for Veterinary Medical Ethics and a symposium for the Southeastern Pharmacology Society
  • NIH supported research on renin-angiotensin
Research Focus:
  • Renin-angiotensin system and regulation of the cardiovascular system by the brain
  • Development and analysis of novel compounds to study the renin-angiotensin system
  • Radioligand preparation and use to study receptors
  • Development of a novel rodent brain atlas
  • Neurodegenerative diseases
Malav S. Trivedi, Ph.D., Assistant Professor
Malav Trivedi
Scholarly Activities:
  • Recipient of $500,000 in research/scholarship grants from private organizations and funding agencies as co-investigator or principal investigator
  • Reviewer for three scientific journals
  • Associate editor for the Journal of Frontiers in Biosciences
Research Focus:
  • Nutritional biochemistry and molecular effects of nutritional interventions in vitro, in vivo, and in clinical samples
  • Pre-clinical and clinical evaluation of metabolic and epigenetic changes on nuclear and mitochondrial DNA in neurodevelopmental disorders
  • Tumor biology and microenvironment
  • Gulf war illness and chronic fatigue syndrome
Silvia E. Rabionet, Ed.D., Chair and Associate Professor
Silvia Rabionet
Scholarly Activities:
  • Served as principal investigator or co-investigator on various research grants
  • Published 15 articles and abstracts in professional journals
  • Co-authored one book chapter
  • Co-authored a book and 5 technical reports
Research Focus:
  • Health disparities
  • Public health issues
  • Research capacity building in HIV
Manuel J. Carvajal, Ph.D., Professor Emeritus
Manuel Carvajal
Scholarly Activities:
  • Author/editor of 8 books
  • Over 120 journal articles, reports, and book chapters
  • Reviewer for over 10 scientific journals
Research Focus:
  • Applied econometrics geared to problem solving
  • Various areas of human capital including fertility, migration, poverty, and discrimination
  • Gender and ethnic differences in labor market outcomes and job satisfaction
  • Pharmacist workforce
Nile M. Khanfar, Ph.D., M.B.A., Associate Professor
Nile Khanfar
Scholarly Activities:
  • Published more than 60 articles and abstracts
  • Over 70 presentations in national and international conferences
  • Served as a reviewer for multiple scientific journals
Research Focus:
  • Management leadership
  • Strategic management/marketing business cases
  • Direct-to-consumer advertising of prescription medication and its influence on their behavior
Alexandra Perez Rivera, Pharm.D., Associate Professor
Leanne Lai
Scholarly Activities:
  • Participated in 9 funded internal and external research grants
  • Over 30 peer-reviewed scientific papers and abstracts
  • Over 60 presentations at local, national, and international pharmacy and non-pharmacy conferences
  • Manuscript reviewer for several pharmacy and diabetes-related journals
  • Grant reviewer or panel chair for the American Association of Colleges of Pharmacy New Investigator Award and the NSU President’s Faculty Research and Development Grant Programs
Research Focus:
  • Type 2 diabetes outcomes
  • Pharmacoepidemiology and pharmacoeconomics
  • Racial/ethnic disparities
  • Pharmacy health services
Ioana Popovici, Ph.D., Associate Professor
Ioana Popovici
Scholarly Activities:
  • Served as investigator on several grants and contracts funded by the National Institute on Drug Abuse, the National Institute on Alcohol Abuse and Alcoholism, and the Florida State Department of Children and Families
  • Published 42 peer-reviewed articles in multidisciplinary, professional journals
  • Co-authored 7 book chapters and reports
  • Frequent referee for 27 peer-reviewed professional journals
Research Focus:
  • Specialized in the economics of substance use. Research interests pursued along four interconnected lines:
    1) economic evaluation of substance use disorder treatment interventions,
    2) relationship between substance use and its economic consequences,
    3) econometric methods for studying substance use, and
    4) effect of public policies on substance use and health outcomes
  • Pharmacist workforce
Jesús Sánchez, Ph.D., Associate Professor
Jesuz Sanchez
Scholarly Activities:
  • Garnered in excess of $1.9 million in research grant funding
  • Published 15 manuscripts in professional journals
  • Authored one book
  • Made 36 presentations at international and national meetings
Research Focus:
  • HIV reduction among high risk Hispanic migrant workers
  • Building capacity and infrastructure in the migrant farm worker communities of South Florida
  • Susceptibility to pesticide toxicity in the endocrine systems of migrant farm workers
  • Prevalence of HIV, Hepatitis B and C, and associated risk factors among Hispanic intravenous drug users
Georgina Silva-Suárez, Ph.D., Assistant Professor
Georgina Suarez
Scholarly Activities:
  • Co-investigator on a research grant awarded by the National Institute of Allergy and Infectious Diseases
  • Principal investigator of a developmental grant component of a grant awarded by the National Institute for HIV and Mental Health
  • Co-author of 3 journal articles
  • Over 20 presentations at national and international scientific meetings
Research Focus:
  • Adherence to antiretroviral therapy
  • HIV prevention
  • Life experiences of youth living with HIV
  • Adolescent health
Patrick W. Sullivan, Ph.D., Professor
Georgina Suarez
Scholarly Activities:
  • published over 70 peer-reviewed primary research articles: https://www.ncbi.nlm.nih.gov/myncbi/1l5_2LRagwgQ89/bibliography/public/
  • Over 100 abstracts, poster and oral presentations at scientific conferences
  • Consulted for the Institute of Medicine, the Consumer Product Safety Commission, and numerous private companies on HEOR methodologies and applications
  • Acted as Principal Investigator on over 25 HEOR research grants from government agencies, and pharmaceutical and biotechnology companies, with funding over $2 million
  • Served as editor for Medical Decision Making and reviewer for numerous HEOR and clinical journals
Research Focus:
  • Health Economics and Outcomes Research (HEOR)
  • Cost-effectiveness Modeling
  • Real-world Evidence (RWE) – Retrospective Data Analyses
  • Patient Reported Outcomes (PRO), Health Utility
Return to top of page